Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started
Sign up to stay up to date with the stocks you care about
Follow PALATIN TECHNOLOGIES INC

Get SEC filing alerts via email and in your feed for PALATIN TECHNOLOGIES INC

PTN PTNT

PALATIN TECHNOLOGIES INC

About PALATIN TECHNOLOGIES INC

Palatin Technologies, Inc. is a biopharmaceutical company focused on developing receptor-specific medicines targeting the melanocortin receptor system. Its products aim to treat inflammatory, autoimmune, metabolic, and rare diseases, including obesity, dry eye disease, and inflammatory bowel conditions. The company leverages proprietary peptides and small molecules, collaborates with industry partners, and seeks regulatory approval to commercialize innovative therapies with broad therapeutic potential.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PALATIN TECHNOLOGIES INC

1
1
2
1
3
1
4
1
5
1
6
1